Psychiatry Month in Review: April 2024
This month in review features top psychiatry news in the pipeline, FDA approvals, and a piece for autism awareness month.
Source: hcplive.com
Larry Ereshefsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Larry Ereshefsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Larry Ereshefsky Today - Breaking & Trending Today
Advancing Brilaroxazine Research in Schizophrenia with Larry Ereshefsky, PharmD
In an interview, Larry Ereshefsky, PharmD, discussed other conditions brilaroxazine could potentially treat other than schizophrenia due to its mechanism.
Source: hcplive.com
Larry Ereshefsky, PharmD: Brilaroxazine Improves Schizophrenia Symptoms
Larry Ereshefsky, PharmD, discussed the effects of brilaroxazine on inflammatory cytokines and neuroinflammation and how this can impact future schizophrenia treatment.
Source: hcplive.com
Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
- Successfully met primary endpoint; brilaroxazine 50 mg delivered a statistically significant and clinically meaningful 10.1-point reduction in Positive and Negative Syndrome Scale total score vs....
Source: marketscreener.com
Positive Topline Results Reported for Phase 3 Clinical Trial Evaluating Schizophrenia Treatment
The trial’s results showed statistically significant reductions in all major symptom domains and secondary endpoints.
Source: psychiatrictimes.com